CYKLOKAPRON

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Estonia, Finland, Ireland, Malta, Netherlands, New Zealand, Singapore, South Africa, UK.

Active ingredients

The drug CYKLOKAPRON contains one active pharmaceutical ingredient (API):

1	Tranexamic acid UNII 6T84R30KC1 - TRANEXAMIC ACID
	Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i.e., actions similar to aminocaproic acid. Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid. Tranexamic acid binds more strongly than aminocaproic acid to both the strong and weak receptor sites of the plasminogen molecule in a ratio corresponding to the difference in potency between the compounds.
	Read more about Tranexamic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CYKLOKAPRON Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02AA02	Tranexamic acid	B Blood and blood forming organs → B02 Antihemorrhagics → B02A Antifibrinolytics → B02AA Amino acids
Discover more medicines within B02AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2180R
CA	Health Products and Food Branch	02064405, 02064413
EE	Ravimiamet	1051816, 1051827, 1065967, 1083316
FI	Lääkealan turvallisuus- ja kehittämiskeskus	021899, 459859
GB	Medicines & Healthcare Products Regulatory Agency	13548, 27735
IE	Health Products Regulatory Authority	19186, 19194
MT	Medicines Authority	AA1438/04301, AA505/05102
NL	Z-Index G-Standaard	13871110
NL	Z-Index G-Standaard, PRK	1562, 4626
NZ	Medicines and Medical Devices Safety Authority	2776, 2777
SG	Health Sciences Authority	02487P, 02488P
US	FDA, National Drug Code	0013-1114
ZA	Health Products Regulatory Authority	H/8.1/806, H/8.1/807